Toward a chronotherapy of ovarian cancer. Part III: Salivary CA125 for chronochemotherapy by efficacy.
Cornélissen
G
G
University of Minnesota, Minneapolis.
Halberg
F
F
Halberg
E
E
Bingham
C
C
Haus
E
E
Bast
R C
RC
Fujii
S
S
Long
H J
HJ
Halberg
F
F
Tamura
K
K
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism; D002909:Chronobiology Phenomena; D002945:Cisplatin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000517:prevention & control; D017239:Paclitaxel / Q000008:administration & dosage; D012463:Saliva / Q000276:immunology
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D017239:Paclitaxel; D002945:Cisplatin